Monday, September 22, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Title Wolfe Research Analyst Initiates Coverage of Corteva with Outperform Rating and 67 Price Target

Elaine Mendonca by Elaine Mendonca
March 2, 2024
in Breaking News
0
Finance_Capitalistic
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

Wolfe Research analyst Chris Parkinson has recently started covering Corteva (NYSE: CTVA) with an Outperform rating. This analysis was initiated on February 29th and March 1st, 2024. According to Wolfe Research, Corteva has been given an “outperform” rating with a price target of $67.00. Capital IQ reports that the consensus among analysts also leans towards an outperform rating for Corteva, with price targets ranging from $53 to $70.

Corteva Inc. (CTVA) Stock Market Performance Analysis: March 2, 2024

On March 2, 2024, Corteva Inc. (CTVA) saw a positive performance in the stock market. The stock closed at $53.66, which was a $0.14 increase from the previous market close, representing a 0.26% rise in price. CTVA’s performance on this day was notable for a few reasons.

One key indicator of CTVA’s performance is its position relative to its 52-week range and its 200-day simple moving average. CTVA was trading in the middle of its 52-week range on March 2, indicating that the stock has not reached extreme highs or lows compared to its performance over the past year. Additionally, CTVA was trading above its 200-day simple moving average, suggesting that the stock has been on an overall upward trend in the longer term.

While CTVA’s price increase on March 2 was relatively small, the stock’s stability in after-hours trading is also worth noting. The fact that CTVA remained unchanged in after-hours trading indicates that investors were generally confident in the stock’s performance and did not feel the need to sell off their shares after the market closed.

Overall, CTVA’s performance on March 2, 2024, reflects a stable and positive trend in the stock market. With its position in the middle of its 52-week range and above its 200-day simple moving average, CTVA appears to be a solid investment option for investors looking for steady growth in the agricultural sector.

CTVA Stock Performance Review: Mixed Results in Financial Metrics on March 2, 2024

On March 2, 2024, CTVA stock showed mixed performances in terms of its financial metrics. According to data from CNN Money, the company reported total revenue of $17.23 billion for the past year, which remained flat compared to the previous year. Similarly, the total revenue for the fourth quarter was reported at $3.71 billion, also holding flat since the previous quarter.

In terms of net income, CTVA reported a net income of $735.00 million for the past year, representing a decrease of 35.92% compared to the previous year. However, the net income for the fourth quarter showed a positive trend, with a reported loss of $233.00 million, representing an increase of 26.73% since the previous quarter.

Earnings per share (EPS) for CTVA stock were reported at $1.03 for the past year, showing a decrease of 34.79% compared to the previous year. The EPS for the fourth quarter was reported at -$0.36, which remained flat compared to the previous quarter.

Overall, CTVA stock showed mixed performances in its financial metrics on March 2, 2024. While total revenue remained flat, net income showed a decrease compared to the previous year but an increase compared to the previous quarter. Earnings per share also showed a decrease compared to the previous year but remained flat compared to the previous quarter. Investors and analysts will be closely monitoring CTVA’s financial performance in the coming quarters.

Tags: CTVA
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post

Analyst Optimistic about Eli Lilly Cos Promising Future

Finance_Accounting (2)

Analyst Maintains Neutral Rating on Forward Air Lowers Price Target

EEFT stock news

Analyst at Morgan Stanley Increases Price Target for Clearway Energy

Recommended

Stepan Stock

Mixed Signals for Stepan as Earnings Climb Yet Disappoint

4 weeks ago
NTST stock news

Analysis of Strs Ohio’s Stake Reduction in NETSTREIT Corp and Company Outlook

2 years ago
Guidewire Software Stock

Guidewire’s Strategic Push Into Japan Coincides With Executive Stock Sales

4 days ago
Maui Land, Pineapple Stock

Hawaiian Land Developer Considers Strategic Water Asset Divestment

1 week ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

AAPL Adobe Alibaba Alphabet Amazon AMD AMZN Apple ASML BA BigBear.ai BioNTech Broadcom Coinbase Eli Lilly Fiserv Hims & Hers IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Opendoor Oracle Oxford Lane Capital Palantir Pepsi Red Cat Robinhood Rocket Lab USA Salesforce Strategy Tesla Tilray TSLA Unitedhealth Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

National Bankshares: Strong Fundamentals Clash with Market Selling Pressure

Luxury Giant Richemont Navigates Cybersecurity Crisis

Semiconductor Shakeup: Intel and Nvidia Forge $5 Billion Alliance Targeting AMD

MP Materials Set for S&P MidCap 400 Inclusion Amidst Operational Headwinds

Strong iPhone 17 Debut Fuels Optimism for Apple

Plug Power’s Resurgence: Sustainable Momentum or Fleeting Rally?

Trending

Investors Title Stock
Banking & Insurance

A Quiet Performer: Investors Title Posts Stellar Quarterly Results

by Dieter Jaworski
September 22, 2025
0

While market attention frequently centers on major technology stocks, a lesser-known title insurance provider is delivering exceptional...

Celcuity Stock

Celcuity Stock: High-Priced Biotech With Blockbuster Potential

September 22, 2025
Claros Mortgage Trust Stock

Claros Mortgage Trust Faces Mounting Institutional Skepticism

September 22, 2025
National Bankshares Stock

National Bankshares: Strong Fundamentals Clash with Market Selling Pressure

September 22, 2025
Compagnie Financiere Richemont Stock

Luxury Giant Richemont Navigates Cybersecurity Crisis

September 22, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • A Quiet Performer: Investors Title Posts Stellar Quarterly Results
  • Celcuity Stock: High-Priced Biotech With Blockbuster Potential
  • Claros Mortgage Trust Faces Mounting Institutional Skepticism

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com